Podcast
 |
| On this edition of The Burrill Report: Jim Greenwood, president and CEO of the Biotechnology Industry Organization, discusses the uncertainty surrounding healthcare reform, what it means for issues such as follow-on biologics, and what the industry's policy agenda looks like for 2010. |
G. Steven Burrill
Welcome from the CEO
Flash required to view this video. Download the latest version here
G. Steven BurrillNews
Biotech holds steady in January as broader markets head south February 01, 2010 | Press Release
Biotech Closes the Year on an Upswing January 04, 2010 | Press Release
Biotech gets back on track in November December 01, 2009 | Press Release
See all News
The Burrill & Company team consists of about 70 people focused exclusively on the life sciences. It includes senior life science professionals who have been seconded from Burrill's large corporate limited partners: ADM, Bayer CropScience, Bayer Healthcare, DSM, IBM, Mitsubishi, Nestlé, Novo A/S, Priority Healthcare and Unilever.
Our Advisory Boards include some of the most respected professionals in the industry including CEOs, Nobel Laureates and other industry luminaries.
Venture Group
G. Steven Burrill
Chief Executive Officer
Governor Tommy G. Thompson
Venture Partner
Victor Hebert
Managing Director
Chief Administrative Officer and Chief Legal Officer
João Paulo Poiares Baptista
Managing Director
John E. Hamer
Managing Director
Ann F. Hanham
Managing Director
Ganesh Kishore
CEO, Malaysian Life Sciences Capital Fund
Tania Fernandez
Director - India
Roger E. Wyse
Managing Director
Bryant E. Fong
Managing Director
Michael Keyoung, MD, PhD
Managing Director, Burrill Pan-Asia
Greg B. Young
Director
Marietta Wu
Director
Garrett Vygantas, M.D.
Director
Stephen M. Sammut, MBA
Venture Partner
Giovanni A. Ferrara
Venture Partner
Simon Waddington
Entrepreneur-in-Residence
Gabriela Cezar, Ph.D.
Venture Partner
John H. Kim, M.D.
Venture Partner
Veronica Descotte
Associate, Latin America
Merchant Banking
G. Steven Burrill
Chief Executive Officer
Victor Hebert
Managing Director
Chief Administrative Officer and Chief Legal Officer
James D. Watson
Managing Director
Shawn Cross
Managing Director
Anton Gueth
Managing Director
Hal Gerber, MD
Managing Director
Stephen Kujawa
Director
Christa Nicholas
Director
Tiba Aynechi
Director
Dave Raksin
Director
Sergey Axenovich
Associate
Steven Zhou
Analyst
Benjamin P. Chen
International Director
Private Equity
G. Steven Burrill
Chief Executive Officer
Hal Gerber, MD
Managing Director
Michael Keyoung, MD, PhD
Director
Burrill International Group
G. Steven Burrill
Chief Executive Officer
John E. Hamer
Managing Director
Ann F. Hanham
Managing Director
Ganesh Kishore
CEO, Malaysian Life Sciences Capital Fund
Hal Gerber, MD
Managing Director
Roger E. Wyse
Managing Director
Bryant E. Fong
Managing Director
Holly Apgar
Director
Michael Keyoung, MD, PhD
Managing Director, Burrill Pan-Asia
Greg B. Young
Director
Garrett Vygantas, M.D.
Director
Stephen M. Sammut, MBA
Venture Partner
Giovanni A. Ferrara
Venture Partner
Gabriela Cezar, Ph.D.
Venture Partner
Veronica Descotte
Associate, Latin America
Marietta Wu
General Manager, Greater China
Benjamin P. Chen
International Director
Media Group
G. Steven Burrill
Chief Executive Officer
Michaela Bjorkman
Director, Business Development
Leslie Errington
Director, Business Development
Peter Winter
Director of Communications
Lucy Clarke
European Editor
Thea Schwartz Johnson
Director, Events
Daniel S. Levine
Web Editor
The Journal of Life Sciences
Jennifer Gregoire
Project Manager, Events
Administration
Monique Tjong
Staff Accountant
Mike San Pedro
Facilities Coordinator
Susan Panell
Receptionist
Mary Lopes
Executive Assistant to the Venture Group
Mary Patterson
Executive Assistant Merchant Banking
Jean Yang
Accounting Manager
Helena Sen
Controller
Sarah Thompson
Executive Assistant to the CEO
Victor Hebert
Managing Director
Chief Administrative Officer and Chief Legal Officer
Cristina Komarowski Gerber
Execuctive Assistant to Victor Hebert
Grace Carino
Second Executive Assistant to the CEO